Clinical trial
Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung…
NCT00003062 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00003062 |
|---|---|
| Title | Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer |
| Official title | A Phase II Study of TEMOZOLOMIDE in Advanced Non-Small Cell Lung Cancer With and Without Brain Metastases |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | temozolomide |
| Enrollment | 70 |
| Start date | Jul 1, 1997 |
| Primary completion | Jan 1, 2002 |
| First posted | Feb 16, 2004 |
| Last update posted | Jul 2, 2012 |
| Countries | Italy, Netherlands, Poland, South Africa, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: